Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.
Kip, Anke E; Balasegaram, Manica; Beijnen, Jos H; Schellens, Jan H M; de Vries, Peter J; Dorlo, Thomas P C.
Antimicrob Agents Chemother
; 59(1): 1-14, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25367913
Determinants for the development of visceral leishmaniasis disease.
Cutaneous leishmaniasis in North Dakota.
Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India.
Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
Cutaneous and mucocutaneous leishmaniasis: Clinical perspectives.
Recurrent leishmaniasis in kidney transplant recipients: report of 2 cases and systematic review of the literature.
Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.
Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.
Identification and glycobiological characterization of circulating immune complexes in patients with visceral leishmaniasis and post kala azar dermal leishmaniasis.
Expression profiling of Sudanese visceral leishmaniasis patients pre- and post-treatment with sodium stibogluconate.